ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
March 23, 2023
Research dictionary entry
March 23, 2023
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Winter 2023

Summaries of recently reported ECOG-ACRIN research results
Do you like it?
0 Read more
January 5, 2023
Video thumbnail
January 5, 2023
Categories
  • Editorials

Video: The Patient Voice

Watch a few of the ECOG-ACRIN cancer research advocates explain why cancer research is about more than just science
Do you like it?
0 Read more
January 5, 2023
January 5, 2023
Categories
  • New Trials

Now Enrolling: The BRIDGE research study is evaluating a new treatment approach for patients with early bladder cancer

This study is for patients who have aggressive, high-grade tumors that put them at higher risk of recurrence after treatment
Do you like it?
0 Read more
January 5, 2023
January 5, 2023
Categories
  • Ongoing Trials

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)
Do you like it?
0 Read more
Prev page
12345
Next page

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Tags

Acute lymphoblastic leukemia Adolescents and young adults Advocacy Bladder cancer Breast cancer Caregiving Communication De-escalation Head and neck cancer Health equity HER2+ breast cancer Immune system therapy Immunotherapy In memory Kidney cancer Leukemia Lung cancer Lymphoma Mammography Mantle cell lymphoma Melanoma Multiple myeloma Myeloma NCI-MATCH Nose and sinus cancer Pancreatic cancer Pancreatic cysts Patient care Personalized medicine Personalized screening Personalized treatment Precision medicine Prevention Prostate cancer Renal cell carcinoma Research results Sarcoma Screening Side effects Squamous cell carcinoma Surveillance Survivorship Symptom management Targeted therapy Throat cancer

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc